Phosphorodiamidate-Directed Metalation of N-Heterocycles using Mg- and Zn-TMP Bases
摘要:
The strong directing ability of the N,N,N',N'-tetramethyldiaminophosphorodiamidate group has been used to achieve selective metalations on various heterocycles such as pyridines, quinolines and quinoxalines with TMP-derived bases like TMPMgCl.LiCl, TMP2Mg.2LiCl, and TMP2Zn.2MgCl(2).2LiCl. This protocol was applied in the synthesis of etoricoxib, talnetant and a P-selectin inhibitor.
Phosphorodiamidate-Directed Metalation of N-Heterocycles using Mg- and Zn-TMP Bases
摘要:
The strong directing ability of the N,N,N',N'-tetramethyldiaminophosphorodiamidate group has been used to achieve selective metalations on various heterocycles such as pyridines, quinolines and quinoxalines with TMP-derived bases like TMPMgCl.LiCl, TMP2Mg.2LiCl, and TMP2Zn.2MgCl(2).2LiCl. This protocol was applied in the synthesis of etoricoxib, talnetant and a P-selectin inhibitor.
PYRIDONE GPR119 G PROTEIN-COUPLED RECEPTOR AGONISTS
申请人:Bristol-Myers Squibb Company
公开号:EP2170864A1
公开(公告)日:2010-04-07
US4517192A
申请人:——
公开号:US4517192A
公开(公告)日:1985-05-14
[EN] PYRIDONE GPR119 G PROTEIN-COUPLED RECEPTOR AGONISTS<br/>[FR] AGONISTES DU RÉCEPTEUR GPR119 COUPLÉ À LA PROTÉINE G PYRIDONE
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2009012275A1
公开(公告)日:2009-01-22
Novel compounds are provided which are GPR119 G protein-coupled receptor modulators. GPR119 G protein-coupled receptor modulators are useful in treating, preventing, or slowing the progression of diseases requiring GPR119 G protein-coupled receptor modulator therapy. These novel compounds have the structure Formula (I) or Formula (IA).